Effectiveness of tuberculosis treatment in individuals exposed to silica or with silicosis: a systematic review and meta-analysis
In brief
TB mortality odds were 2.5 times higher with silicosis, but evidence is very uncertain
In a review of seven studies, people with TB and silicosis had an estimated 2.5 times higher odds of death than those with TB alone; estimates also leaned toward more treatment failure and recurrence. But the studies were few, often biased, and the evidence was rated very low certainty, so whether silicosis worsens treatment outcomes remains unclear.
- Journal
- BMC public health (Q1)
- Published
- 4 August 2026
- Study design
- Systematic review / meta-analysis of RCTs
- Evidence level
- Level 1, High (CEBM 1a)
- Authors
- Meckie Achayo, David Rees, Nandi Siegfried, Rodney Ehrlich
- PMID
- 43009848
- DOI
- 10.1186/s12889-026-28779-y
Why clinicians should know about it
- Picked for Pulmonary and Respiratory Medicine (top studies of the week, 15 November 2026): Systematic review of tuberculosis outcomes with silica exposure
- Picked for Public Health, Environmental and Occupational Health (top studies of the week, 15 November 2026): Occupational silica exposure and tuberculosis treatment outcomes
- Picked for Epidemiology (paper of the day, 12 November 2026): Assesses silica exposure, confounding, and tuberculosis treatment outcomes
Abstract
BACKGROUND: Tuberculosis (TB) is a global problem affecting large numbers of workers exposed to respirable crystalline silica. Both silicosis and exposure to silica without silicosis increase the risk of active TB. While some studies have suggested that silicotuberculosis (silicosis plus TB) or silica exposure on its own are associated with unsuccessful TB treatment outcomes, the evidence is inconsistent. This systematic review and meta-analysis aimed to compare TB treatment outcomes in individuals with silicotuberculosis to those with TB alone, and similarly in those with TB plus silica exposure to those with TB alone. METHODS: We conducted a systematic review of randomized and nonrandomized trials, and cohort and case-control studies published 1970-2024. Studies were sought which investigated TB treatment outcomes for silicotuberculosis or silica exposure alone via PubMed, Web of Science and Scopus. We conducted risk of bias assessments using ROBINS-E for observational studies of TB treatment (silicosis or silica as the "exposure") and ROB 2 for randomized trials of different TB drug regimens. GRADE was used to assess overall certainty of evidence. RESULTS: Seven studies met the inclusion criteria, all restricted to comparing silicotuberculosis with TB alone or different drug regimens among those with silicotuberculosis. High/very high risk of bias or "some concerns" were noted in six - due to confounding, loss to follow-up, missing data, and/or concerns about exposure or outcome measurement. The pooled odds ratio (OR) for treatment failure/delayed conversion for individuals with silicotuberculosis versus those with TB alone was 1.79 (95% CI 0.54, 5.99; N = 4, very low certainty); for mortality OR 2.45 (95% CI 0.58, 10.39; N = 2, very low certainty); and for TB recurrence OR 1.20 (95% CI 0.01, 134.89; N = 2, very low certainty). The relative risk ratio of recurrence for use of a six versus eight-month TB treatment regimen was 3.29 (95% CI: 0.77, 14.15; N = 1, very low certainty). CONCLUSIONS: The effect estimates among individuals with silicotuberculosis tended towards unfavourable TB treatment outcomes, including higher mortality. However, the evidence base is sparse and suffers from high risk of bias. Accordingly, these findings should be treated with caution. High-quality studies of both silicotuberculosis and silica exposure without silicosis are long overdue to fill this important evidentiary gap.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.